Stock RSLS RESHAPE LIFESCIENCES
Add to a list
To use this feature you must be a member
Log inSign up

All News ReShape Lifesciences OTC Markets

Equities

RSLS

US7611236032

End-of-day quote OTC Markets
Other stock markets
 23:00:00 07/07/2021 BST 		5-day change 1st Jan Change
5.09 USD +23.84% Intraday chart for ReShape Lifesciences -.--% -.--%
05-15 Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024
05-15 Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : ReShape Lifesciences Inc., Q1 2024 Earnings Call, May 15, 2024
Earnings Flash (RSLS) RESHAPE LIFESCIENCES Posts Q1 Revenue $1.9M, vs. Street Est of $2.1M
MT
ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
AQ
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
AQ
North American Morning Briefing : Big Banks Kick -2-
DJ
Transcript : ReShape Lifesciences Inc., Q4 2023 Earnings Call, Apr 01, 2024
ReShape Lifesciences® Reports Year Ended December 31, 2023 Financial Results and Provides Corporate Update
AQ
ReShape Lifesciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Certain Restricted Stock Units of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Warrants of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Options of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
Certain Common Stock of ReShape Lifesciences Inc. are subject to a Lock-Up Agreement Ending on 30-MAR-2024.
CI
ReShape Lifesciences Gets US Patent for Intragastric Balloon Weight-Loss System
MT
ReShape Lifesciences® Receives Notice of Allowance for Additional U.S. Patent Related to an Intragastric Balloon System
AQ
ReShape Lifesciences Receives Notice of Allowance for Additional U.S. Patent Related to Intragastric Balloon System
CI
ReShape Lifesciences® Provides Update on 2024 Cost Reduction Plan and Reorganization to Prioritize Commercialization of Lap-Band® 2.0 FLEX
AQ
ReShape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band® 2.0 FLEX
AQ
Reshape Lifesciences® Announces First Surgeries Utilizing Next-Generation Lap-Band 2.0 Flex
CI
ReShape Lifesciences® Conducts Bariatric Fellows Training for its Lap-Band® System, Highlighting the Next-Generation Lap-Band® 2.0 FLEX
AQ
ReShape Lifesciences announces FDA PMA supplement approval for next-gen Lap-Band 2.0 Flex
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. RSLS Stock
  4. RSLS Stock
  5. News ReShape Lifesciences